Get started
Award

82401265

Funded outputs count: 7
Funder award ID: 82401265
OpenAlex ID: G7122455851
The potential of ruxolitinib as a senomorphic therapy in alleviating neovascular age-related macular degeneration
2026 · Yinhao Wang, Zhihua Huang, et al. · Journal of Translational Medicine
Rationally designed light-inducible RNA-releasing protein for translational regulation and optogenetic control of gene therapies
2026 · Shichao Li, Ting Gao, et al. · Trends in biotechnology · 3
Senescence-induced endothelial-to-mesenchymal transition accelerates the subretinal fibrosis in neovascualr age-related macular degeneration
2026 · Yinhao Wang, Huiling Ma, et al. · Journal of Translational Medicine · 5
Mitochondria in corneal physiology and pathology: A mechanistic perspective
2025 · Liusi Yang, Siyi Chen, et al. · Progress in Retinal and Eye Research · 3
Growth factor receptor-bound protein 2-mediated corneal epithelial injury drives depression-associated dry eye disease
2025 · Kuangqi Chen, Ying Li, et al. · Biochemical Pharmacology · 3
Blue light induces corneal epithelial damage by activating the NLRP3 inflammasome pathway
2025 · Jiayun Ge, Qianjie Yang, et al. · Ecotoxicology and Environmental Safety · 1
Notoginsenoside R1 alleviates blue light-induced corneal injury and wound healing delay by binding to and inhibiting TRIB1
2025 · Kuangqi Chen, Jiafeng Li, et al. · Phytomedicine · 6
Year
Topic